Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Kranzer, Katharina ^a,b   Zeinecker, Jennifer ^a   Ginsberg, Philip ^a   Orrell, Catherine ^a   Kalawe, Nosindiso N ^c   Lawn, Stephen D ^a,b   Bekker, Linda Gail ^a   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c False Bay Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH SERVICE; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COUNSELING; PRENATAL CARE; SCREENING TEST; SEX DIFFERENCE; SOUTH AFRICA; TREATMENT PLANNING; URBAN AREA; COMMUNITY CARE; HEALTH CARE DELIVERY; PREVALENCE; STATISTICS; TIME;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COMMUNITY HEALTH SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; SOUTH AFRICA; TIME FACTORS;

EID: 78149478090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013801     Document Type: Article

References (40)

1. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance (2009) Epidemiological fact sheet on HIV and AIDS, Core data on epidemiology and response, South Africa. Geneva.
2. Karim SS, Churchyard GJ, Karim QA, Lawn SD (2009) HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 24: 24.
3. Adam MA, Johnson LF (2009) Estimation of adult antiretroviral treatment coverage in South Africa. S Afr Med J 99: 661-667.
4. South African National AIDS Council/Department of Health (2010) South African antiretroviral treatment guidelines. Pretoria.
5. Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, et al. (2000) Costeffectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356: 113-121.
6. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, et al. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One 5: e9538.
7. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51: 135-139.
8. Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med 168: 86-93.
9. Middelkoop K, Wood R, Myer L, Whitelaw A, Kaplan R, et al. Widespread ART is associated with decline in TB prevalence; 2009; Cape Town, South Africa.
10. Lawn SD, Kranzer K, Wood R (2009) Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med 30: 685-699, viii.
11. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
12. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175: 87-93.
13. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157: 940-943.
14. South African Government (2003) Operational plan for comprehensive HIV and AIDS care, management and treatment for South Africa. Pretoria, South Africa.
15. UNAIDS (2003) Handbook on access to HIV/AIDS-related treatment: a collection of information, tools and other resources for NGOs, CBOs and PLWHA. Geneva, Switzerland.
16. Kitahata MM, Tegger MK, Wagner EH, Holmes KK (2002) Comprehensive health care for people infected with HIV in developing countries. BMJ 325: 954-957.
17. World Health Organization (2003) Treatment of tuberculosis: guidelines for national programmes. Geneva.
18. Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, et al. (2009) Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 50: 148-152.
19. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S (2006) Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 43: 42-46.
20. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, et al. (2008) Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr 48: 181-189.
21. Ghebreyesus TA, Kazatchkine M, Sidibe M, Nakatani H (1757) Tuberculosis and HIV: time for an intensified response. Lancet 375: 1757-1758.
22. Remien RH, Chowdhury J, Mokhbat JE, Soliman C, Adawy ME, et al. (2009) Gender and care: access to HIV testing, care, and treatment. J Acquir Immune Defic Syndr 51(Suppl 3): S106-110.
23. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7: 63.
24. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R (2009) The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health 14: 722-731.
25. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: 290.
26. MacPherson P, Moshabela M, Martinson N, Pronyk P (2009) Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans R Soc Trop Med Hyg 103: 588-593.
27. Zachariah R, Harries K, Moses M, Manzi M, Line A, et al. (2009) Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health 14: 713-721.
28. Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M (2009) Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 14: 36-43.
29. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, et al. (2007) Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect 55: 464-469.
30. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438.
31. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, et al. (2006) Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 43: 78-84.
32. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Aids 22: 1897-1908.
33. Nacher M, El Guedj M, Vaz T, Nasser V, Randrianjohany A, et al. (2006) Risk factors for follow-up interruption of HIV patients in French Guiana. Am J Trop Med Hyg 74: 915-917.
34. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach (2010 version). Geneva.
35. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, et al. (2009) Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr 52: 397-405.
36. Larson BA, Brennan A, McNamara L, Lawrence L, Rosen S, et al. (2010) Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bulletin of the World Health Organization.
37. Larson BA, Brennan A, McNamara L, Long L, Rosen S, et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15(Suppl 1): 43-47.
38. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lowerincome countries. Bull World Health Organ 86: 559-567.
39. Brinkhof MW, Pujades-Rodriguez M, Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4: e5790.
40. Rosen S, Fox MP, Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.